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Abstract: In this study, the effects of the size and Chinese traditional processing (including 
elutriation, water cleaning, acid cleaning, alkali cleaning) on realgar nanoparticles (RN)-induced 
antitumor activity in human osteosarcoma cell lines (MG-63) and hepatoma carcinoma cell lines 
(HepG-2) were investigated. The human normal liver cell line (L-02) was used as control. RN 
was prepared by high-energy ball milling technology. The results showed that with the assistance 
of sodium dodecyl sulfate, the size of realgar could be reduced to 127 nm after 12 hours’ ball 
milling. The surface charge was decreased from 0.83 eV to -17.85 eV and the content of As2O3 
clearly increased. Except for elutriation, the processing methods did not clearly change the size 
of the RN, but the content of As2O3 was reduced dramatically. In vitro MTT tests indicated that 
in the two cancer cell lines, RN cytotoxicity was more intense than that of the coarse realgar 
nanoparticles, and cytotoxicity was typically time- and concentration-dependent. Also, RN 
cytotoxicities in the HepG-2 and L-02 cells all increased with increasing milling time. Due to 
the reduction of the As2O3 content, water cleaning, acid cleaning, and alkali cleaning decreased 
RN cytotoxicity in HepG-2, but RN after elutriation, with the lowest As2O3 (3.5 mg/g) and the 
smallest size (109.3 nm), showed comparable cytotoxicity in HepG-2 to RN without treatment. 
Meanwhile, RN-induced cytotoxicity in L-02 cells was clearly reduced. Therefore, it can be 
concluded that RN may provide a strong antiproliferation effect in the MG-63 and HepG-2 cells. 
Elutriation processing is a suitable approach to limit the dangerous side-effects of As2O3, while 
maintaining the effectiveness of RN.
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Introduction
Realgar (Xiong-Huang in Chinese), an arsenic-containing Chinese traditional mineral 
drug (its major component is As2S2 or As4S4), has been used for treatment of various 
diseases, such as carbuncles, scalds and burns, insect-bites, abdominal pains, infantile 
convulsions, and psoriasis, for more than 1500 years.1–4 Especially in recent years, 
with the confirmation of its clinical effectiveness for the treatment of some varieties 
of refractory or relapsed tumor or cancer, realgar has attracted increasing attention 
in the biomedical field.5 In particular, previous investigations showed that realgar is 
absorbed rapidly and excreted mostly within the first 24 hours’ urine.6 Unfortunately, 
poor natural water solubility and thus poor bioavailability greatly hampers wider 
clinical applications of realgar. It has been reported that only 0.10% and 0.40% of the 
coarse realgar (CR) powder dissolves in the stomach and intestinal fluids, and is finally 
absorbed.4 Therefore, there is an urgent need for methods to safely and effectively 
deliver poorly water-soluble realgar.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Due to its inherent nonionizable property, there is 
a   limited number of chemical approaches available to 
overcome the disadvantages of realgar. Therefore, realgar 
nanoparticles (,100 nm in diameter) were proposed and 
several strategies have been used to reduce the size of realgar 
in the past few years. It has been proved that the physical 
and chemical properties of realgar and other nanoparticles 
can be significantly improved or radically changed as their 
size is scaled down to small clusters of atoms, especially 
in clinical applications.6 The ensuing in vitro and in vivo 
experiments revealed that the size indeed had dramatic 
effect on the antitumor activity of realgar. Compared with 
CR, realgar nanoparticles (RN) exhibited greater toxicity 
in a cervical cancer cell line (HeLa), three human ovarian 
cancer cell lines (CI80-13S, OVCAR, OVCAR-3),6 and nor-
mal ECV-304 cells.7 Accordingly, in our previous study, our 
group also endeavored to prepare RN by high-energy milling 
technology. The results revealed that the disintegration of 
realgar particles was accompanied by an obvious increase in 
arsenic trioxide (As2O3) from 2.82 to 9.75 mg/g. Research has 
shown that inorganic As2O3 is the most toxic arsenic species 
and can induce complete remission in a high percentage of 
patients with refractory acute promyelocytic leukemia.8–11 
However, the high toxicity and severe side effects, especially 
in long-term use, make it unacceptable in clinic settings.12 
That is to say, reduction of the As2O3 content of RN should 
be considered prior to clinical use.
Processing is a widely used method to reduce the toxicity 
of traditional Chinese medicines. The most commonly used 
processing methods include elutriation, water cleaning, acid 
cleaning, and alkali cleaning. To date, the effects of these 
processing methods on the As2O3 content and the change in 
resulting antitumor activity have never been investigated.
In this study, our first objective was to prepare RN and 
investigate the cytotoxicity of the prepared RN in human 
osteosarcoma cell lines (MG-63) and human hepatoma 
carcinoma cell lines (HepG-2), which has not been reported 
previously. Our second objective was to study the effect 
of processing method (elutriation, water cleaning, acid 
cleaning, and alkali cleaning) on the physicochemical 
properties and cytotoxicity of RN in MG-63 and HepG-2 
cell lines. The cytotoxicity of RN in human normal liver cell 
line was also investigated for comparison, and the potential 
apoptosis induction of RN particles after processing was 
investigated, too. RN were prepared by high-energy milling 
technology with the help of sodium dodecyl sulfate (SDS) 
at room temperature. The cytotoxicity was evaluated by 
MTT assay.
Materials and methods
Materials
Realgar (As2S2, 98% in purity) was purchased from Hubei 
Province. Arsenic trioxide (As2O3) was kindly provided by 
Zhongshan Hospital. SDS (Junsei, Japan) has been used 
previously in milling tests as a surfactant. MG-63, HepG-2, 
and L-02 cell lines were purchased from the American Type 
Culture Collection (ATCC).
Methods
Preparation of rN by high-energy ball milling
The ball milling equipment (Nanjing University Instrument 
Plant, Nanjing, China) was used to reduce the particle size 
of realgar powder. There were four grinding vials in the 
equipment and pure realgar powder (5.0 g) was also added 
with SDS aqueous solution (saturated concentration) to 
each vial. The rate of milling ball and realgar was W(balls)/
W(realgar) = 40/1 and rate of rotation was 400 rpm. These 
four realgar preparations were ground simultaneously to 
produce particles under the same operating conditions. In 
order to study how the process altered RN size, three ball-
milling times were chosen: 4, 8, and 12 hours.
Processing methods of the as-prepared rN
The as-prepared RN was processed by the following four 
methods: elutriation, water cleaning, acid cleaning, and alkali 
cleaning. The corresponding RN obtained were named E-RN, 
WC-RN, ACI-RN, and ALK-RN, respectively.
1.  Elutriation: 10 g RN powder and 5 mL distilled water 
were first added into a mortar. After 5 minutes’ grind-
ing, 100 mL distilled water was added and then agitated 
for 1 minute. The solution stood for 10 minutes, then 
the clear supernatant liquid was collected and the coarse 
powder remaining was ground again. This procedure was 
repeated eleven times to obtain E-RN.
2.  Water cleaning: 10 g RN powder and 100 mL distilled 
water were added to a beaker and agitated for 30 minutes. 
Sucking filtration was then carried out and the processed 
RN were collected. This procedure was repeated eleven 
times to obtain WC-RN.
3.  Acid cleaning: 10 g RN powder and 100 mL dilute hydro-
chloric acid solution were added to a beaker and agitated 
for 30 minutes. Sucking filtration was then carried out 
and the RN processed was collected. This procedure was 
repeated eleven times to obtain ACI-RN.
4.  Alkali cleaning: 10 g RN powder and 100 mL dilute 
caustic soda solution (3%) were added to a beaker and International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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agitated for 30 minutes. Sucking filtration was then   carried 
out and the RN processed was collected. This   procedure 
was repeated eleven times to obtain ALK-RN.
characterization
X-ray diffraction measurement (XRD, D/max 2550 VB/PC; 
Rigaku, Tokyo, Japan) and Fourier transform infrared 
spectrometer (Nicolet-5700 FTIR; Nicolet, Waltham, MA) 
were used to study the changes in phase and chemical 
composition of the RN. XRD was carried out by using a 
diffractometer X Perth MPD working in the 2θ geometry 
with Cu Kα radiation at room temperature. Measurements 
were done at 40 kV voltage, 40 mA current, and a scanning 
angle (2θ) range 0° to 90°.
Particle size distribution and zeta potential were 
determined by a Zetasizer (Mastersizer 2000; Malvern 
Instruments, Malvern, UK). The testing conditions were 
as follows: the dispersal medium was ultrapure water; 
RN concentration was 0.25 mg/mL; the suspension was 
sonicated for 5 minutes before measuring; and each different 
milling time condition of the realgar filtrate was analyzed 
and compared. A scanning electron microscope (JEM-2010 
HR SEM; JOEL, Tokyo, Japan) was used to examine the 
morphology of the ground RN and also to physically measure 
the size of the ground RN.
Assay of the As2O3 content
As2O3 content was assayed by the classical Ag-DDC method. 
In brief, arsenic was reduced by Zn into arsenic trihydride in a 
solution of dissolved potassium iodide and stannous chloride. 
Then the arseniuretted hydrogen was passed through the lead 
acetate solution in order to remove hydrogen sulfide in the 
gas, and the remaining pure gas was passed through silver 
diethyldithiocarbamate-triethanolamine-trichloromethane 
mixed solution. The Ag+ was then reduced to red colloidal 
silver, and the absorbance of colloidal silver was compared 
with the standard arsenic solution to assay the content of 
elemental As.
cytotoxicity determination
In this study, MG-63, HepG-2, and L-02 cells were used to 
test the cytotoxicity of the RN. Three cell lines were cultured 
in 37.5 cm2 flasks with growth medium (Dulbecco’s modified 
Eagle’s medium (GIBCO, Grand Island, NY) containing 
10% fetal calf serum (Sijiqing, Hangzhou, China), antibiotics 
(100 U/mL penicillin-G, 100 mg/mL streptomycin) at 
37°C in humidified atmosphere of 5% CO2/95% air until 
confluence, then detached with 0.25% trypsin/0.03% 
ethylenediamine tetraacetic acid (EDTA) and the cell density 
was calculated.
These cells were preincubated in 96-well plates at a 
  density of 5000 cells/well. After 24 hours, the cells were 
treated with different concentrations of RN for a determined 
time (24, 48, and 72 hours). Then, the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) labeling 
  solution was added onto the plates containing the RN-treated 
MG-63, HepG-2, and L-02 cells. After further incubation for 
4 hours, the cells were lysed and the purple formazan crystals 
were solubilized for detection at 570 nm.
Flow cytometry analysis of apoptosis  
and cell cycle distribution
Based on the cytotoxicity tests for RN, apoptosis was 
identified and quantified by flow cytometry using HepG-2 
cell lines. Cells were treated with various RN for 24 hours. 
At the end of the incubation, all cells were collected and 
fixed in 70% ice-cold ethanol at a cell density of 1 × 106/mL, 
and kept at 4°C at least overnight until analysis. Fixed 
cells were washed twice with PBS buffer and treated with 
1 mg/mL RNAse (DNAse-free) (Sigma Chemical Co Ltd, 
Shanghai, China) for 30 minutes at 37°C. Propidium iodine 
(polydispersity index [PI] $95% in purity, Sigma) was then 
added to the solution at a final concentration of 50 µg/mL 
and subjected to flow cytometry.
statistical analysis
Statistical analysis was performed using SPSS software 
(v 11.0; SPSS, Inc, Chicago, IL). Significant difference 
between two groups was evaluated by Student’s t-test and 
the level of significance was set at P , 0.05.
Results
rN preparation
In order to achieve optimal grinding of the realgar, the 
main experimental conditions, including milling time 
and concentration of added SDS, were first optimized. 
  Figure 1 shows the size of the RN after 4, 8, and 12 hours 
grinding with the SDS concentration at 2.48 g/L, which is the 
saturated concentration of SDS. Figure 1 clearly shows that 
average RN particle size declined as milling time increased. 
After 4 and 8 hours’ milling, RN with average diameters of 
469 nm and 327 nm were obtained. After 12 hours, the effec-
tive diameter of the powders was reduced to 127 nm. Further 
increased milling time did not decrease particle size further.
With the assistance of SDS, the mean particle sizes 
were greatly decreased, especially with 2.48 g/mL SDS, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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to ,200 nm. In addition, PI, which represents the pattern of 
systematic particle distribution, of the co-ground preparations 
was significantly lower than that of the ground realgar 
alone, suggesting that the particle distribution became more 
homogeneous after grinding with additive(s) (Table 1).
These results led to the selection of a milling time of 
12 hours and an SDS concentration of 2.48 g/mL for the 
subsequent preparation of RN. Figure 2 displays the repre-
sentative image of the RN prepared at the optimal conditions. 
The morphologies of the prepared RN were irregular and the 
size ranged from 100 nm to 300 nm.
characterization of the as-prepared rN
After determining the main conditions, we investigated the 
changes of the phase and chemical compositions, and the 
surface potential after milling. The results are presented in 
Figures 3 and 4, and Table 2. The characterized diffraction 
peaks observed in the RN were in agreement with that of 
the original realgar powder (Figure 3). The XRD patterns 
showed a lot of overlapping peaks and the peaks were very 
close to those filed in the JCPDS card file (No. 09-0441) for 
α-As2S2 crystal. Also, the sharp diffraction peaks indicated 
good crystallization of the as-prepared As2S2 nanocrystals. 
In addition, a relatively higher background was observed, 
meaning that a small amorphous fraction was probably pres-
ent in the sample as a consequence of high-energy milling. 
The results confirmed that the selected high-energy milling 
technique did not obviously change the crystallinity of the 
realgar powder.
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Figure 1 Particle size distribution of the realgar nanoparticles milled with sodium 
dodecyl sulfate for 4, 8, and 12 hours.
Figure 2 representative seM image of the realgar nanoparticles milled for 12 hours.
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Figure 3 X-ray diffraction patterns of realgar: (A) untreated sample, (B) milled with 
sodium dodecyl sulfate for 12 hours.
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Similarly, from the comparison of FTIR spectra of the RN 
and CR (Figure 4) it can be seen that after ball milling, the 
characteristic absorption bands corresponding to the realgar 
peak at about 343–344 cm-1 and 375–376 cm-1 did not change 
significantly. That is to say, the ball-milling process has little 
apparent effect on chemical compositions. However, the 
content of As2O3 as determined by Ag-DDC assay indicates 
that after grinding with and without the addition of SDS, the 
content of As2O3 increased from 2.82 mg/g to 11.25 mg/g 
and 9.75 mg/g, respectively.
The zeta potential values of the original realgar powder 
and realgar ground particles without SDS were almost zero 
(Table 2). After grinding in the presence of SDS, the zeta 
potential values decreased to –17.85 mV .
effect of the processing method  
on rN physicochemical properties
Table 2 shows that, apart from elutriation, the processing 
method had no apparent effect on the particle size and the 
PI of the as-prepared RN. Clearly, after elutriation, RN 
not only became smaller, but was also distributed more 
homogeneously.
The results also indicate that As2O3 content in RN after 
all processing methods significantly decreased, except for 
alkali cleaning, after which As2O3 content increased after 
processing. In contrast, elutriation reduced As2O3 level 
to 6.25 mg/g, the minimum level achieved, meaning that 
  elutriation was the most effective method of removing 
As2O3 in RN.
cytotoxicity of prepared rN
The potential in vitro cytotoxicity of the various RN in the 
MG-63, HepG-2 cells is shown in Figures 5 and 6. It can be 
seen that CR and RN all had a cytotoxic effect in the MG-63 
and HepG-2 cells. In contrast, in both HepG-2 cells and 
MG-63 cells, RN cytotoxicity at all times was remarkably 
higher than that of the CR in the tested range of 25–400 µg/mL. 
That is to say, RN cytotoxicity was more intense than that 
of the CR. In addition, cell viabilities of HepG-2 cells and 
MG-63 cells all decreased dramatically with increases in 
time and concentration in a typical time- and concentration-
dependent manner (Figures 5 and 6). It is worthwhile noting that 
the IC50 of the HepG-2 cells and MG-63 cells after 72 hours was 
45.2 µg/mL and 52.5 µg/mL, respectively. That is, HepG-2 cells 
were likely more sensitive to RN than MG-63 cells.
After exposure to RN for 72 hours at a concentration 
of 400 µg/mL, the viabilities of HepG-2 and L-02 cells 
all decreased with length of milling time. In contrast, RN 
exhibited significantly higher cytotoxicity in HepG-2 cells 
than in L-02 cells (P , 0.05) (Figure 7).
effect of processing on rN cytotoxicity
As with untreated RN, RN cytotoxicity after different pro-
cessing methods all increased with increasing concentration 
(Figure 8). In contrast, the efficacy of antitumor activity 
decreased in the order of untreated RN . ALK-RN . WC- 
RN . ACI-RN . E-RN. It is worth noting that, compared 
with RN treated by other processing methods, E-RN of the 
smallest size and the lowest As2O3 content exhibited the 
strongest cytotoxicity in HepG-2 cells, almost as high as that 
of unprocessed RN at high concentration (Figure 9).
After 72 hours’ cultivation at 400 µg/mL, compared with 
RN without processing, cytotoxicity of E-RN in HepG-2 was 
almost unchanged, but the viability of L-02 clearly increased 
from 85.2% to 95.4%, comparable with the 96% viability 
after treatment by CR at the same concentration and for the 
same time.
Table 1 Particle size of realgar nanoparticles milled with different 
sodium dodecyl sulfate (sDs) concentrations
Size (nm) Polydispersity index
crude realgar – 0.892 ± 0.145
realgar milled without additive 328.3 ± 3.7 0.522 ± 0.095
sDs at 1.24 g/L 249.8 ± 5.3 0.493 ± 0.213
sDs at 2.48 g/L 127.5 ± 4.6 0.242 ± 0.103
Table 2 As2O3 content in realgar nanoparticles (rN) and zeta potential treated by different processing methods
Size  
(nm)
Polydispersity 
index
Zeta potential  
(mV)
As2O3 content 
(mg/g)
crude realgar – 0.892 ± 0.145   0.83 ± 0.3 2.82
realgar milled without additive 328.4 ± 3.7 0.522 ± 0.095   0.93 ± 0.5 11.25
rN with sDs 127.5 ± 4.6 0.172 ± 0.103 -17.85 ± 1.7 9.75
elutriation 109.3 ± 3.7 0.105 ± 0.112 -18.01 ± 2.3 3.50
Water cleaning 124.2 ± 4.1 0.195 ± 0.098 -16.94 ± 1.8 5.66
Acid cleaning 129.6 ± 4.9 0.167 ± 0.093 -16.77 ± 1.1 4.75
Alkali cleaning 133.6 ± 5.6 0.170 ± 0.094  - 17.1 ± 1.9 9.26International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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effects of rN treated by different 
processing methods on apoptosis 
induction in hepg-2 cells
Hardly any apoptotic cells were detected in the control group 
(Figure 10). However, in RN-treated groups, a large number 
of cells undergoing apoptosis were detected, showing that 
RN can induce high apoptosis in HepG-2 cells.
After incubation with RN at a concentration of 400 µg/mL 
for 24 hours, flow cytometry analysis of DNA content showed 
that the percentages of cells undergoing apoptosis were 
4.19%, 59.32%, 52.87%, 56.71%, 54.52%, and 62.5%, for the 
control group, RN, elutriation, water cleaning, acid cleaning, 
and alkali cleaning treatments, respectively. However, there 
was a minor difference between the values of cells in the 
late stage of apoptosis.
Discussion
Recently, RN have received substantial attention since 
their   successful clinical application for the treatment of 
hematopoietic malignancies, especially for acute promyelocytic 
leukemia. In this work, we wanted to   continue these studies in 
order to understand the size effect of RN-induced cytotoxicity 
in MG-63 and HepG-2, two representative cancer cell lines. 
Furthermore, we wanted to reduce the As2O3 in RN by 
traditional processing and further study the effect of processing 
on antitumor activity and the side-effects of RN.
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Figure 5 effect of realgar nanoparticles (rN) on viability of hepg-2 cells. Various 
concentrations of rN (A) and crude realgar (B) were added to the media: 400 µg/mL, 
200 µg/mL, 100 µg/mL, 50 µg/mL, 25 µg/mL.
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Figure 6 effect of realgar nanoparticles (rN) on viability of Mg-63 cells. Various 
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types of realgar nanoparticles (rN) for 24 hours (400 µg/mL).
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size reaches the minimum. After the balance time point, the 
particle size enlarges again because the rate of dispersion 
is less than the rate of reuniting. On this premise, it can be 
inferred that 12 hours is the balance time point for realgar. 
Our data also showed that SDS, especially at the saturated 
concentration of 2.48 g/L, greatly contributed to the reduced 
size of realgar. We believe that this phenomenon could be 
attributed to effective wetting of the realgar surface, providing 
a steric and/or ionic barrier, and inhibition of recrystallization 
and/or aggregation of realgar particles in water.
The size reduction of realgar particles by high-energy 
milling is always accompanied by an increase in their number 
and by the generation of fresh, previously unexposed surface. 
In this study, the widely used high-energy grinding 
technology with water-soluble surfactants was applied to 
scale down the particle size of realgar. The data showed that 
extending milling time within the initial 12 hours reduced 
the size of realgar. But after this time point, time had no 
apparent effect on particle size. It is well accepted that the 
milling process is an equilibrium process, in which the 
interaction process is affected by aggregation and dispersion 
processes.13,14 Within a certain period, the dispersion process 
is stronger than the reuniting process and the particle size 
declines as the time is increased. This resignation phase is 
followed by a balance phase. At this point in time, the rate 
of dispersion is equal to the rate of reuniting and the particle International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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Therefore, in this study we compared the   physicochemical 
properties of the RN before and after milling. XRD patterns 
and FITC spectra confirmed that after milling, the main 
phase and chemical composition were apparently unaltered. 
The results in Table 2 also showed that after milling, the 
zeta potential of the RN was reduced from almost zero to a 
  negative value, probably because realgar is nonionizing. After 
grinding, negatively charged SDS was partially adsorbed 
onto the surface of the RN and thus the zeta potential values 
became negative.
In order to reduce the content of As2O3 in realgar, different 
processing methods applied in Chinese traditional medicine 
for thousands of years were used in this study. Data showed 
that, as expected, As2O3 content could be effectively reduced 
when treated by all processing methods except for alkali 
cleaning. The reason we conjectured is that the dilute caustic 
soda in solution might have reacted with As2S2, thus resulting 
in the transformation of As2S2 to As or As2O3. In contrast, 
the elutriation process produced the highest reduction in 
As2O3. The data obtained also indicated that there was only a 
marginal difference between the zeta potentials of RN treated 
by the different methods. Additionally, there was a slight 
difference in particle size between all RN processing methods 
except for elutriation. XRD and FTIR (data not shown) also 
showed that none of the processing methods had any clear 
effects on the main phase and chemical compositions.
The in vitro cytotoxicity test showed that, consistent with 
the previous investigations,6,7,15 RN inhibited growth of the two 
selected tumor cell lines more significantly than CR, especially 
after 72 hours’ incubation. Further, comparing the two tumor 
cell lines showed that HepG-2 cells were likely more sensitive 
than MG-63 cells. Meanwhile, by   comparing the effects of real-
gar of various particle sizes on the cellular viability of the cancer 
cell lines and human normal cell lines, it can be concluded that 
the size of the realgar nanoparticles is the key element for the 
effect of antitumor activity. Also, RN of smaller size and higher 
As2O3 exhibited slight cytotoxicity to L-02.
The in vitro cytotoxicity results also indicated that, com-
pared with RN without processing, RN cytotoxicities after 
processing decreased in the order of untreated RN . ALK-
RN . WC-RN . ACI-RN . E-RN. According to our study, 
the untreated RN, ALK-RN, WC-RN, and ACI-RN used here 
possessed similar phase and chemical composition, particle 
size, and zeta potential. Their cytotoxicity showed a similar 
trend with the content of As2O3. Based on these results, in can 
be hypothesized that As2O3 content had a predominant effect 
on RN cytotoxicity. E-RN, however, had the lowest As2O3 
content and showed comparable cytotoxicity to untreated 
RN. We think this may be attributable to its smaller particle 
size. Previous investigations have asserted that particle size 
plays a critical role in the cellular uptake of nanoparticles 
and thereby their bioactivity. Cellular uptake of smaller 
nanoparticles is often greater than that of larger nanoparticles, 
especially when the size is .100 nm. Thus, although E-RN 
contained the lowest As2O3, it could induce the strongest 
cytotoxicity in HepG-2 cells. Further results indicated that, 
as expected, after elutriation the viability of L-02 was obvi-
ously increased, meaning a lessening of the side effects of 
RN after elutriation.
Apoptosis, or programmed cell death, is an important 
way to maintain cellular homeostasis between cell division 
and cell death. Dysregulation of apoptosis is linked to the 
development of most cancers. Thus, an induction of apoptosis 
in cancer cells is considered as a new focus in the discovery 
of anticancer drugs. So, in this study, to further understand 
RN-initiated cytotoxicity, we examined the possibility of 
apoptosis-induction by RN in HepG-2. The results confirmed 
that RN both before and after all processing treatments 
clearly induced apoptosis in HepG-2, especially the early 
stages of apoptosis.
Conclusion
In this study, RN were successfully produced by a ball-
milling method with the assistance of SDS. RN with an 
average diameter of about 127 nm could be obtained after 
12 hours milling at an SDS concentration of 2.48 g/L. 
Compared with CR, the as-prepared RN exhibited a 
stronger antiproliferation effect on the HepG-2 and MG-63 
cell lines, and the RN-induced cytotoxicity was typically 
size-, concentration-, and time-dependent. Also, the RN 
cytotoxicities in the HepG2 and L-02 cells all increased 
as particle size was reduced. The processing methods, 
including water cleaning, acid cleaning, and alkali cleaning, 
all decreased As2O3 content, thus reducing cytotoxicity. But 
the RN treated by elutriation with the lowest As2O3 (3.5 mg/g) 
and the smallest size (109.3 nm) exhibited comparable 
cytotoxicity in HepG-2 to untreated RN. Meanwhile, the side 
effects of RN were effectively reduced. Lastly, RN with or 
without processing can induce apoptosis in HepG-2 cells.
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